SG biomedical sector sees growth with more than $500m investment:Report

SG biomedical sector sees growth with more than $500m investment:Report

biopharmaceuticals. Credit: Flickr/Laurence Livermore

The Singaporean life sciences industry presents a compelling space for investors and entrepreneurs, says Kevin Lai, executive director of Biomedical Sciences and Consumer Businesses at the Singapore Economic Development Board (EDB), in an interview.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter